DVA DaVita Inc.

  • DVA
  • Price as of: Oct 21, 06:40 PM EDT
  • $60.96
  • -$0.14
  • -0.2%
  • Industry
  • Specialized health services

DVA Stock Dividend Data

Add DVA to Watchlist
  • Dividend Yield
    0.00% Healthcare Average 0.99%
  • Annualized Payout
  • Payout Ratio
    0.0% EPS $3.77
  • Dividend Growth
    No Payout Increase Last Year
  • Get DVA DARS™ Rating

Looking to buy or sell DVA?

Buy Now
Sell Now
Upcoming Dividend Payouts

DVA Upcoming Dividend Payouts

DVA has not yet officially announced its next dividend payout.
DARS Rating™ Breakdown

Dividend.com DARS Rating™ Breakdown for DVA

Metric Ranking Avg Ranking Notes
Stock not rated.
Yield History

DVA Dividend Yield & Stock Price History

Dividend Payout History

DVA Dividend Payout History

No Payout History Is Available

Brought to You by Mitre Media

Growth History

DVA Dividend Growth History

Annualized Growth
Annualized Growth
Annualized Growth
Annualized Growth
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Years of
Reveal More Dividend Growth History for DVA
Historical Annual Dividend Data & Growth

DVA Historical Annual Dividend Data & Growth

Payout Amount Calendar Year Annual Growth
No Payout History Is Available
Historical Dividend Data

DVA Dividend History

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
No Payout History Is Available
Company Profile

DVA Company Profile

Exchange: NYSE
Sector: Healthcare

DaVita Inc. (DVA) is a provider of dialysis treatment for patients suffering from chronic kidney failure. The company focuses on providing dialysis and administrative services within their 1,809 outpatient dialysis centers in 42 states, helping 142,000 patients. In addition, it provides acute inpatient dialysis services in around 900 hospitals in the US. The company was founded in 1994 and is based in Denver, CO.

High Yield Stocks

High Yield Stocks

Looking for dividend stocks with great yields? Visit our list of:

High Yield Dividend Stocks

DaVita Inc. News

  • When a big-ticket celebrity investor like Warren Buffet makes a move, the world takes notice. This is what happened in the last few months. Even when he buys something reasonable, people start to debate over the timing of the trade or why some...

  • DaVita Healthcare Downgraded By Deutsche Bank (DVA, HCP)

    Denver-based kidney care company DaVita Healthcare Partners (DVA) was downgraded from "Buy" to "Hold" by Deutsche Bank on Thursday. Analysts also lowered the price target from $136 to $130. DVA announced a deal with healthcare properties investor HCP (HCP) in May of 2012 and shares have been responding well to the possible shift in focus. "Given the heightened risks in the Medicare Advantage space, where HCP derives most of its profits, we believe risk/reward is now more in balance," noted analysts in explaining their downgrade. Shares of DVA opened at $119 after closing at $122 Wednesday night and are still moving down. The stock has gained about 36% since announcing its deal with HCP in May, but is down almost 3% today. Shares of DaVita (DVA) are currently not rated by Dividend.com. HCP is currently rated "Neutral," holding a Dividend.com DARS™ rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story